Berbamine inhibits the infection of SARS-CoV-2 and flaviviruses by compromising TPRMLs-mediated endolysosomal trafficking of viral receptors
Lihong Huang(City University of Hong Kong), Jianbo Yue(Duke Kunshan University), Zuodong Ye(City University of Hong Kong), Hin Chu(University of Hong Kong), Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Qiang Fu(City University of Hong Kong), Yang Yang(Chinese Academy of Sciences), Qiang Xu(Northeast Agricultural University), Huanan Li(South China Agricultural University), Wei Sun(City University of Hong Kong), Guoliang Zhang(Qingdao Agricultural University), Terrence Tsz‐Tai Yuen(Sichuan University), Wenbao Qi(Northeast Agricultural University)
Cited by 10
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k